Terms: = Germ cell tumor AND MALAT1, PRO1073, 378938, Q9UHZ2 AND Treatment
16 results:
1. Deconstructing the role of malat1 in MAPK-signaling in melanoma: insights from antisense oligonucleotide treatment.
Feichtenschlager V; Zheng YJ; Ho W; Chen L; Callanan C; Chen C; Lee A; Ortiz J; Rappersberger K; Ortiz-Urda S
Oncotarget; 2023 May; 14():543-560. PubMed ID: 37235843
[TBL] [Abstract] [Full Text] [Related]
2. Influence of the Cultivation Conditions of the Glioblastoma Neurosphere on the Expression of malat1 and LINCROR Long Non-coding RNA Genes.
Mazur DV; Mishanova AV; Kovalenko TF; Shakhparonov MI; Antipova NV
Dokl Biochem Biophys; 2023 Feb; 508(1):21-24. PubMed ID: 36653583
[TBL] [Abstract] [Full Text] [Related]
3. The evaluation expression of non-coding RNAs in response to HSV-G47∆ oncolytic virus infection in glioblastoma multiforme cancer stem cells.
Vazifehmand R; Ali DS; Othman Z; Chau DM; Stanslas J; Shafa M; Sekawi Z
J Neurovirol; 2022 Dec; 28(4-6):566-582. PubMed ID: 35951174
[TBL] [Abstract] [Full Text] [Related]
4. Long non-coding RNAs as a predictive markers of group 3 medulloblastomas.
Mutlu M; Tekin C; Ak Aksoy S; Taskapilioglu MO; Kaya S; Balcin RN; Ocak PE; Kocaeli H; Bekar A; Tolunay S; Tunca B
Neurol Res; 2022 Mar; 44(3):232-241. PubMed ID: 34533098
[TBL] [Abstract] [Full Text] [Related]
5. LncRNA malat1 promotes glioma cell growth through sponge miR-613.
Su Y; Liang C; Yang Q
J BUON; 2021; 26(3):984-991. PubMed ID: 34268963
[TBL] [Abstract] [Full Text] [Related]
6. Genomic analyses of high-grade neuroendocrine gynecological malignancies reveal a unique mutational landscape and therapeutic vulnerabilities.
Mahdi H; Joehlin-Price A; Elishaev E; Dowlati A; Abbas A
Mol Oncol; 2021 Dec; 15(12):3545-3558. PubMed ID: 34245124
[TBL] [Abstract] [Full Text] [Related]
7. Coexistence of TERT C228T mutation and malat1 dysregulation in primary glioblastoma: new prognostic and therapeutic targets.
Ak Aksoy S; Mutlu M; Tunca B; Kocaeli H; Taskapilioglu MO; Bekar A; Tekin C; Argadal OG; Civan MN; Kaya İS; Ocak PE; Tolunay S
Neurol Res; 2021 Nov; 43(11):916-925. PubMed ID: 34210246
[No Abstract] [Full Text] [Related]
8. Reconstruction of lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveals functional lncRNAs in skin cutaneous melanoma.
Zhu J; Deng J; Zhang L; Zhao J; Zhou F; Liu N; Cai R; Wu J; Shu B; Qi S
BMC Cancer; 2020 Sep; 20(1):927. PubMed ID: 32993558
[TBL] [Abstract] [Full Text] [Related]
9. Long non-coding RNA malat1 aggravates human retinoblastoma by sponging miR-20b-5p to upregulate STAT3.
Wang L; Zhang Y; Xin X
Pathol Res Pract; 2020 Jun; 216(6):152977. PubMed ID: 32336590
[TBL] [Abstract] [Full Text] [Related]
10. Temozolomide treatment Induces lncRNA malat1 in an NF-κB and p53 Codependent Manner in Glioblastoma.
Voce DJ; Bernal GM; Wu L; Crawley CD; Zhang W; Mansour NM; Cahill KE; Szymura SJ; Uppal A; Raleigh DR; Spretz R; Nunez L; Larsen G; Khodarev NN; Weichselbaum RR; Yamini B
Cancer Res; 2019 May; 79(10):2536-2548. PubMed ID: 30940658
[TBL] [Abstract] [Full Text] [Related]
11. Long non-coding RNAs in melanoma.
Yu X; Zheng H; Tse G; Chan MT; Wu WK
Cell Prolif; 2018 Aug; 51(4):e12457. PubMed ID: 29582492
[TBL] [Abstract] [Full Text] [Related]
12. Long noncoding RNA malat1 knockdown reverses chemoresistance to temozolomide via promoting microRNA-101 in glioblastoma.
Cai T; Liu Y; Xiao J
Cancer Med; 2018 Apr; 7(4):1404-1415. PubMed ID: 29479863
[TBL] [Abstract] [Full Text] [Related]
13. Targeted nanocomplex carrying siRNA against malat1 sensitizes glioblastoma to temozolomide.
Kim SS; Harford JB; Moghe M; Rait A; Pirollo KF; Chang EH
Nucleic Acids Res; 2018 Feb; 46(3):1424-1440. PubMed ID: 29202181
[TBL] [Abstract] [Full Text] [Related]
14. Long Non-Coding RNA malat1 Decreases the Sensitivity of Resistant Glioblastoma cell Lines to Temozolomide.
Li H; Yuan X; Yan D; Li D; Guan F; Dong Y; Wang H; Liu X; Yang B
Cell Physiol Biochem; 2017; 42(3):1192-1201. PubMed ID: 28668966
[TBL] [Abstract] [Full Text] [Related]
15. Knockdown of Long Noncoding RNA (lncRNA) Metastasis-Associated Lung Adenocarcinoma Transcript 1 (malat1) Inhibits Proliferation, Migration, and Invasion and Promotes Apoptosis by Targeting miR-124 in Retinoblastoma.
Liu S; Yan G; Zhang J; Yu L
Oncol Res; 2018 May; 26(4):581-591. PubMed ID: 28550678
[TBL] [Abstract] [Full Text] [Related]
16. malat1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.
Chen W; Xu XK; Li JL; Kong KK; Li H; Chen C; He J; Wang F; Li P; Ge XS; Li FC
Oncotarget; 2017 Apr; 8(14):22783-22799. PubMed ID: 28187000
[TBL] [Abstract] [Full Text] [Related]
